These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22427189)

  • 1. Use of RNA isolated from feces as a promising tool for the early detection of colorectal cancer.
    Bernal G
    Int J Biol Markers; 2012 Jul; 27(2):e82-9. PubMed ID: 22427189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advances in early diagnosis of colorectal cancer based on detection of RNAs in stool.].
    Qi ZT; Deng LL; Huang H; Zhao JH; Zhou GH
    Yi Chuan; 2010 Oct; 32(10):994-1002. PubMed ID: 20943486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early detection of colorectal cancer: from conventional methods to novel biomarkers.
    Vatandoost N; Ghanbari J; Mojaver M; Avan A; Ghayour-Mobarhan M; Nedaeinia R; Salehi R
    J Cancer Res Clin Oncol; 2016 Feb; 142(2):341-51. PubMed ID: 25687380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening and surveillance for colorectal cancer: state of the art.
    Kahi CJ; Anderson JC; Rex DK
    Gastrointest Endosc; 2013 Mar; 77(3):335-50. PubMed ID: 23410695
    [No Abstract]   [Full Text] [Related]  

  • 5. Stool DNA testing: a new, noninvasive option for colorectal cancer screening.
    Ahlquist DA
    Clin Adv Hematol Oncol; 2015 Jul; 13(7):432-4. PubMed ID: 26353038
    [No Abstract]   [Full Text] [Related]  

  • 6. Colorectal Cancer Screening: Stool DNA and Other Noninvasive Modalities.
    Bailey JR; Aggarwal A; Imperiale TF
    Gut Liver; 2016 Mar; 10(2):204-11. PubMed ID: 26934885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternatives to colonoscopy for population-wide colorectal cancer screening.
    Leung WC; Foo DC; Chan TT; Chiang MF; Lam AH; Chan HH; Cheung CC
    Hong Kong Med J; 2016 Feb; 22(1):70-7. PubMed ID: 26744124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal DNA for noninvasive diagnosis of colorectal cancer in immunochemical fecal occult blood test-positive individuals.
    Calistri D; Rengucci C; Casadei Gardini A; Frassineti GL; Scarpi E; Zoli W; Falcini F; Silvestrini R; Amadori D
    Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2647-54. PubMed ID: 20929882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential of faecal RNA in diagnosing colorectal cancer.
    Yang SH; Chien CC; Chen CW; Li SY; Huang CJ
    Cancer Lett; 2005 Aug; 226(1):55-63. PubMed ID: 16004932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression analysis using a highly sensitive DNA microarray for colorectal cancer screening.
    Koga Y; Yamazaki N; Takizawa S; Kawauchi J; Nomura O; Yamamoto S; Saito N; Kakugawa Y; Otake Y; Matsumoto M; Matsumura Y
    Anticancer Res; 2014 Jan; 34(1):169-76. PubMed ID: 24403458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal immunochemical test accuracy in familial risk colorectal cancer screening.
    Castro I; Cubiella J; Rivera C; González-Mao C; Vega P; Soto S; Hernandez V; Iglesias F; Teresa Alves M; Bujanda L; Fernández-Seara J
    Int J Cancer; 2014 Jan; 134(2):367-75. PubMed ID: 23818169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleic acids from intact epithelial cells as a target for stool-based molecular diagnosis of colorectal cancer.
    Spethmann S; Fischer C; Wagener C; Streichert T; Tschentscher P
    Int J Mol Med; 2004 Mar; 13(3):451-4. PubMed ID: 14767578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal miR-106a is a useful marker for colorectal cancer patients with false-negative results in immunochemical fecal occult blood test.
    Koga Y; Yamazaki N; Yamamoto Y; Yamamoto S; Saito N; Kakugawa Y; Otake Y; Matsumoto M; Matsumura Y
    Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1844-52. PubMed ID: 23950216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stool DNA Integrity Method for Colorectal Cancer Detection.
    Rengucci C; De Maio G; Menghi M; Calistri D
    Methods Mol Biol; 2018; 1765():193-202. PubMed ID: 29589309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRNA as markers for the diagnostic screening of colon cancer.
    Ahmed FE
    Expert Rev Anticancer Ther; 2014 Apr; 14(4):463-85. PubMed ID: 24580550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multitarget stool DNA testing for colorectal-cancer screening.
    Imperiale TF; Ransohoff DF; Itzkowitz SH; Levin TR; Lavin P; Lidgard GP; Ahlquist DA; Berger BM
    N Engl J Med; 2014 Apr; 370(14):1287-97. PubMed ID: 24645800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The toll of not screening for colorectal cancer.
    Chen C; Hoffmeister M; Brenner H
    Expert Rev Gastroenterol Hepatol; 2017 Jan; 11(1):1-3. PubMed ID: 27897033
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel molecular screening approaches in colorectal cancer.
    Miller S; Steele S
    J Surg Oncol; 2012 Apr; 105(5):459-67. PubMed ID: 22441897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the efficacy of screening tests in colorectal cancer by faecal occult blood test--own experience.
    Kozłowski T; Godlewski D; Biczysko M; Grochowalski M; Nelke M; Paszkowski J; Borejsza-Wysocki M; Krokowicz L; Krokowicz P; Banasiewicz T; Drews M
    Pol Przegl Chir; 2011 Aug; 83(8):411-23. PubMed ID: 22166714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.